Galli, Elena
 Distribuzione geografica
Continente #
NA - Nord America 2.028
AS - Asia 1.556
EU - Europa 1.096
SA - Sud America 296
AF - Africa 29
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.022
Nazione #
US - Stati Uniti d'America 1.993
CN - Cina 540
SG - Singapore 449
IT - Italia 435
HK - Hong Kong 240
BR - Brasile 238
GB - Regno Unito 162
VN - Vietnam 148
SE - Svezia 121
RU - Federazione Russa 93
DE - Germania 75
KR - Corea 46
FR - Francia 39
ID - Indonesia 33
FI - Finlandia 29
NL - Olanda 29
AR - Argentina 28
AT - Austria 25
BG - Bulgaria 18
JP - Giappone 17
MX - Messico 17
AU - Australia 16
TR - Turchia 16
MA - Marocco 13
CA - Canada 12
IQ - Iraq 11
LT - Lituania 11
BD - Bangladesh 10
EC - Ecuador 10
PL - Polonia 8
AE - Emirati Arabi Uniti 7
CO - Colombia 7
IE - Irlanda 7
IN - India 7
ES - Italia 6
HU - Ungheria 6
ZA - Sudafrica 6
IL - Israele 5
KG - Kirghizistan 5
PT - Portogallo 5
UA - Ucraina 5
CL - Cile 4
GR - Grecia 4
KE - Kenya 4
PK - Pakistan 4
SA - Arabia Saudita 4
BE - Belgio 3
CZ - Repubblica Ceca 3
EG - Egitto 3
GT - Guatemala 3
IR - Iran 3
PE - Perù 3
BA - Bosnia-Erzegovina 2
CH - Svizzera 2
MY - Malesia 2
PY - Paraguay 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
VE - Venezuela 2
AL - Albania 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
DK - Danimarca 1
EU - Europa 1
IM - Isola di Man 1
JO - Giordania 1
KH - Cambogia 1
LY - Libia 1
MK - Macedonia 1
MU - Mauritius 1
NI - Nicaragua 1
PA - Panama 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 5.022
Città #
Santa Clara 467
Singapore 293
Hefei 238
Hong Kong 238
Ashburn 210
Chandler 150
Fairfield 145
London 93
Nyköping 82
Beijing 73
Ho Chi Minh City 57
Milan 53
Moscow 49
Dallas 47
Seattle 45
Los Angeles 44
Seoul 44
Wilmington 44
New York 43
Cambridge 41
Woodbridge 37
Houston 36
Bologna 32
Chicago 31
Jakarta 27
Shanghai 27
Hanoi 24
Rome 24
Buffalo 23
Princeton 23
San Diego 22
Munich 20
Modena 19
São Paulo 19
Helsinki 17
Nuremberg 17
Sofia 17
Ann Arbor 16
Florence 16
Kent 15
Southend 14
Salt Lake City 13
The Dalles 13
Redondo Beach 12
Reggio Emilia 12
Atlanta 11
Parma 11
Lauterbourg 10
Portsmouth 10
Melbourne 9
Orem 9
Rio de Janeiro 9
Tokyo 9
Vienna 9
Ankara 8
Bremen 8
Brooklyn 8
Council Bluffs 8
Des Moines 8
Lappeenranta 8
Louisville 8
Casablanca 7
Dearborn 7
Dublin 7
Frankfurt am Main 7
Haiphong 7
Padova 7
Warsaw 7
Biên Hòa 6
Boardman 6
Brasília 6
Columbus 6
Elk Grove Village 6
Mexico City 6
Porto Alegre 6
Tampa 6
Trieste 6
Bari 5
Caivano 5
Da Nang 5
Kilburn 5
Montreal 5
Naples 5
Salvador 5
Thái Bình 5
Treviso 5
Zhengzhou 5
Amsterdam 4
Bishkek 4
Brindisi 4
Budapest 4
Bunbury 4
Cagliari 4
Catania 4
Credaro 4
Denver 4
Düsseldorf 4
Guayaquil 4
Huskvarna 4
Hải Dương 4
Totale 3.330
Nome #
INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. WHAT DO WE DON’T KNOW? THE LIRA STUDY (LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS) 275
VEXAS Syndrome: A Case Series From a Single-Center Cohort of Italian Patients With Vasculitis 254
Aortic dilatation in patients with large vessel vasculitis: A longitudinal case control study using PET/CT 241
EULAR guidelines on ANCA-associated vasculitis in the real life 229
Acute-phase reactants during tocilizumab therapy for severe COVID-19 pneumonia 199
AB0611 STRAIN ANALYSIS OF THE RIGHT VENTRICLE USING 2D-SPECKLE TRACKING ECHOCARDIOGRAPHY IN A COHORT OF PATIENTS WITH SYSTEMIC SCLEROSIS 181
Rituximab therapy for primary central nervous system vasculitis: A 6 patient experience and review of the literature 174
Association Between Specimen Length and Number of Sections and Diagnostic Yield of Temporal Artery Biopsy for Giant Cell Arteritis 161
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients 154
THU0600 a case of systemic sclerosis complicated by renal crisis: potential etiopathogenetic role of cytomegalovirus and treatment 144
Effectiveness and safety of a 26-week taper regimen of glucocorticoid in GCA patients: Results from a prospective cohort study 142
Efficacy and safety of TNF-α antagonists and tocilizumab in Takayasu arteritis: Multicenter retrospective study of 209 patients 135
Susceptibility to COVID-19 in Patients Treated With Antimalarials: A Population-Based Study in Emilia-Romagna, Northern Italy 134
Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: A population-based study 130
Vessel inflammation and morphological changes in patients with large vessel vasculitis: A retrospective study 129
The management of large vessel vasculitides 127
Incidence and prevalence of large vessel vasculitis (giant cell arteritis and Takayasu arteritis) in northern Italy: A population-based study 123
Significance of inflammation restricted to adventitial/periadventitial tissue on temporal artery biopsy 122
Resolution of vascular inflammation in patients with new-onset giant cell arteritis: data from the RIGA study 118
Tocilizumab or glucocorticoids treatment for patients with SARS-CoV-2 pneumonia: An observational study 113
Prevalence and distribution of vascular calcifications at CT scan in patients with and without large vessel vasculitis: A matched cross-sectional study 112
Reggio Emilia (Northern Italy) Interdisciplinary Uveitis Clinic: What We Have Learned in the Last 20 Years 112
C-reactive protein gene polymorphisms influence susceptibility and outcomes of biopsy-proven giant cell arteritis in Italian patients 108
Failure of first anti-TNF agent in Takayasu's arteritis: to switch or to swap? 108
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) 105
Development of the Takayasu Arteritis Integrated Disease Activity Index 102
What to Know About Biopsy Sampling and Pathology in Vasculitis? 101
The role of PET/CT in disease activity assessment in patients with large vessel vasculitis 100
Pros and cons of TNF inhibitors and tocilizumab in the treatment of large-vessel vasculitis 95
Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective study 93
The Role of PET in the Diagnosis and Disease Activity Assessment in Large Vessel Vasculitis 93
Response to: COVID-19 in paediatric rheumatology patients treated with b/tsDMARDs: A cross-sectional patient survey study' by Cuceoglu et al 93
Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: the role of imaging in a prospective observational study 92
Senescent cells in giant cell arteritis display an inflammatory phenotype participating in tissue injury via IL-6-dependent pathways 91
Response to ‘The Relevance of Restricted Inflammation in a TAB’ by Griffin KJ et al 90
Reply 81
Current management of giant cell arteritis and its complications 81
Takayasu arteritis and large-vessel giant cell arteritis in Italian population. Comprehensive analysis from a single institutional cohort of 184 cases 80
The role of PET/CT in disease activity assessment in patients with large vessel vasculitis 58
Totale 5.080
Categoria #
all - tutte 25.303
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.303


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021109 0 0 0 0 0 7 4 10 21 18 27 22
2021/2022435 34 18 44 18 14 26 23 24 38 28 98 70
2022/2023590 54 64 33 35 71 76 31 66 82 17 32 29
2023/2024493 12 30 14 58 47 49 59 78 20 33 42 51
2024/20251.740 33 20 23 119 350 293 162 62 177 113 192 196
2025/20261.566 264 188 295 401 357 61 0 0 0 0 0 0
Totale 5.080